from Reuters: Health News https://ift.tt/2L9Zob9
via IFTTT
Tuesday, July 9, 2019
Potential IPO candidate BioNTech secures $325 million in financing round
German biotech firm BioNTech has secured $325 million in a private financing round to boost its cancer immunotherapies pipeline, the company said on Tuesday.
from Reuters: Health News https://ift.tt/2L9Zob9
via IFTTT
from Reuters: Health News https://ift.tt/2L9Zob9
via IFTTT
0 comments:
Post a Comment